A Phase 2, Open-Label, Extension Study to Evaluate the Long- Term Safety and Efficacy of Ubenimex in Patients with Pulmonary Arterial Hypertension (WHO Group 1)
Administered By
Awarded By
Contributors
- Rajagopal, Sudarshan Principal Investigator
Start/End
- August 1, 2016 - July 31, 2018